Endo's Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Endo-Launch-XCOPRI

More Like This

PR Newswire associated0

Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC®

PR Newswire associated0

Endo Launches Colchicine Capsules, Generic Version of MITIGARE®

PR Newswire associated0

Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom

PR Newswire associated0

Endo Announces Divestiture of International Pharmaceuticals Business

PR Newswire associated0

Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada

PR Newswire associated0

Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European Union

PR Newswire associated0

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion

InDex Pharmaceuticals has been granted a new patent for cobitolimod in South Korea